Trademark: AMJEVITA 1786520
Word
AMJEVITA
ID
1786520
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
29 July 2016
Registration Date
29 July 2016
Renewal Date
29 July 2026
Owner(s)
Service
Herbert Smith Freehills
Goods and Services:
Class 5:
Pharmaceutical preparations, including biosimilars; pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, crohn's disease, ulcerative colitis, intestinal behcet's disease, chronic pouchitis, small bowel lesions, hermansky-pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, pyoderma gangrenosum, giant cell arteritis, netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma
Pharmaceutical preparations, including biosimilars; pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, crohn's disease, ulcerative colitis, intestinal behcet's disease, chronic pouchitis, small bowel lesions, hermansky-pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, pyoderma gangrenosum, giant cell arteritis, netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma